Patterson Companies, Inc. (PDCO)

$27.85

-0.55

(-1.94%)

Market is closed - opens 8 PM, 22 Feb 2024

Insights on Patterson Companies, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.57B → 1.65B (in $), with an average increase of 4.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, 31.23M → 39.95M (in $), with an average increase of 21.8% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 40.2% return, outperforming this stock by 39.6%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 185.3% return, outperforming this stock by 195.5%

Performance

  • $27.85
    $28.33
    $27.85
    downward going graph

    0.0%

    Downside

    Day's Volatility :1.68%

    Upside

    1.68%

    downward going graph
  • $23.89
    $33.65
    $27.85
    downward going graph

    14.22%

    Downside

    52 Weeks Volatility :29.0%

    Upside

    17.24%

    downward going graph

Returns

PeriodPatterson Companies, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-12.02%
11.8%
0.0%
6 Months
-16.47%
8.6%
0.0%
1 Year
0.6%
11.4%
-6.3%
3 Years
-11.47%
26.9%
-22.0%

Highlights

Market Capitalization
2.6B
Book Value
$11.21
Dividend Share
1.04
Dividend Yield
3.67%
Earnings Per Share (EPS)
2.05
PE Ratio
13.83
PEG Ratio
2.1
Wall Street Target Price
31.0
Profit Margin
3.05%
Operating Margin TTM
3.67%
Return On Assets TTM
6.21%
Return On Equity TTM
19.04%
Revenue TTM
6.6B
Revenue Per Share TTM
68.1
Quarterly Revenue Growth YOY
1.6%
Gross Profit TTM
1.4B
EBITDA
371.9M
Diluted Eps TTM
2.05
Quarterly Earnings Growth YOY
-0.24
EPS Estimate Current Year
2.36
EPS Estimate Next Year
2.56
EPS Estimate Current Quarter
0.58
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Hold
    36%Buy
    63%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Patterson Companies, Inc.(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
12
13
13
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 11.31%

Current $27.85
Target $31.00

Company Financials

FY18Y/Y Change
Revenue
5.5B
↓ 2.28%
Net Income
201.0M
↑ 17.6%
Net Profit Margin
3.68%
↑ 0.62%
FY19Y/Y Change
Revenue
5.6B
↑ 1.99%
Net Income
83.6M
↓ 58.39%
Net Profit Margin
1.5%
↓ 2.18%
FY20Y/Y Change
Revenue
5.5B
↓ 1.52%
Net Income
-589.4M
↓ 804.75%
Net Profit Margin
-10.74%
↓ 12.24%
FY21Y/Y Change
Revenue
5.9B
↑ 7.69%
Net Income
156.0M
↓ 126.47%
Net Profit Margin
2.64%
↑ 13.38%
FY22Y/Y Change
Revenue
6.5B
↑ 9.93%
Net Income
203.2M
↑ 30.28%
Net Profit Margin
3.13%
↑ 0.49%
FY23Y/Y Change
Revenue
6.5B
↓ 0.43%
Net Income
207.6M
↑ 2.14%
Net Profit Margin
3.21%
↑ 0.08%
Q3 FY22Q/Q Change
Revenue
1.5B
↓ 7.05%
Net Income
24.6M
↓ 61.5%
Net Profit Margin
1.61%
↓ 2.29%
Q4 FY22Q/Q Change
Revenue
1.6B
↑ 6.76%
Net Income
54.1M
↑ 119.9%
Net Profit Margin
3.33%
↑ 1.72%
Q1 FY23Q/Q Change
Revenue
1.6B
↓ 1.56%
Net Income
53.9M
↓ 0.27%
Net Profit Margin
3.37%
↑ 0.04%
Q2 FY23Q/Q Change
Revenue
1.7B
↑ 7.51%
Net Income
75.0M
↑ 39.01%
Net Profit Margin
4.36%
↑ 0.99%
Q3 FY23Q/Q Change
Revenue
1.6B
↓ 8.39%
Net Income
31.2M
↓ 58.34%
Net Profit Margin
1.98%
↓ 2.38%
Q4 FY23Q/Q Change
Revenue
1.7B
↑ 4.82%
Net Income
40.0M
↑ 27.93%
Net Profit Margin
2.42%
↑ 0.44%
FY18Y/Y Change
Total Assets
3.5B
↓ 1.03%
Total Liabilities
2.0B
↓ 4.9%
FY19Y/Y Change
Total Assets
3.3B
↓ 5.83%
Total Liabilities
1.8B
↓ 11.0%
FY20Y/Y Change
Total Assets
2.7B
↓ 16.94%
Total Liabilities
1.9B
↑ 5.04%
FY21Y/Y Change
Total Assets
2.8B
↑ 1.33%
Total Liabilities
1.8B
↓ 4.9%
FY22Y/Y Change
Total Assets
2.7B
↓ 0.36%
Total Liabilities
1.7B
↓ 4.92%
FY23Y/Y Change
Total Assets
2.9B
↑ 5.02%
Total Liabilities
1.8B
↑ 3.63%
Q3 FY22Q/Q Change
Total Assets
2.8B
↑ 0.61%
Total Liabilities
1.7B
↑ 1.9%
Q4 FY22Q/Q Change
Total Assets
2.9B
↑ 4.43%
Total Liabilities
1.8B
↑ 6.18%
Q1 FY23Q/Q Change
Total Assets
2.9B
↑ 2.14%
Total Liabilities
1.8B
↑ 0.07%
Q2 FY23Q/Q Change
Total Assets
2.9B
↓ 2.14%
Total Liabilities
1.8B
↓ 4.29%
Q3 FY23Q/Q Change
Total Assets
2.9B
↑ 0.16%
Total Liabilities
1.8B
↑ 0.67%
Q4 FY23Q/Q Change
Total Assets
2.9B
↑ 0.21%
Total Liabilities
1.8B
↑ 3.51%
FY18Y/Y Change
Operating Cash Flow
178.9M
↑ 9.94%
Investing Cash Flow
17.0M
↑ 1323.89%
Financing Cash Flow
-230.2M
↑ 13.85%
FY19Y/Y Change
Operating Cash Flow
48.2M
↓ 73.08%
Investing Cash Flow
340.7M
↑ 1905.81%
Financing Cash Flow
-355.2M
↑ 54.35%
FY20Y/Y Change
Operating Cash Flow
-243.5M
↓ 605.72%
Investing Cash Flow
499.1M
↑ 46.49%
Financing Cash Flow
-271.2M
↓ 23.65%
FY21Y/Y Change
Operating Cash Flow
-730.5M
↑ 199.95%
Investing Cash Flow
810.7M
↑ 62.41%
Financing Cash Flow
-22.6M
↓ 91.65%
FY22Y/Y Change
Operating Cash Flow
-981.0M
↑ 34.29%
Investing Cash Flow
1.2B
↑ 52.84%
Financing Cash Flow
-253.2M
↑ 1018.28%
FY23Y/Y Change
Operating Cash Flow
-754.9M
↓ 23.05%
Investing Cash Flow
901.6M
↓ 27.24%
Financing Cash Flow
-126.5M
↓ 50.05%
Q3 FY22Q/Q Change
Operating Cash Flow
-302.5M
↑ 106.01%
Investing Cash Flow
238.4M
↓ 18.54%
Financing Cash Flow
73.4M
↓ 145.12%
Q4 FY22Q/Q Change
Operating Cash Flow
-217.6M
↓ 28.07%
Investing Cash Flow
209.5M
↓ 12.1%
Financing Cash Flow
4.1M
↓ 94.47%
Q1 FY23Q/Q Change
Operating Cash Flow
-208.0M
↓ 4.4%
Investing Cash Flow
219.4M
↑ 4.74%
Financing Cash Flow
-9.6M
↓ 336.09%
Q2 FY23Q/Q Change
Operating Cash Flow
-26.7M
↓ 87.19%
Investing Cash Flow
234.3M
↑ 6.75%
Financing Cash Flow
-194.4M
↑ 1927.07%
Q3 FY23Q/Q Change
Operating Cash Flow
-253.4M
↑ 850.54%
Investing Cash Flow
223.8M
↓ 4.46%
Financing Cash Flow
-23.1M
↓ 88.11%

Technicals Summary

Sell

Neutral

Buy

Patterson Companies, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Patterson Companies, Inc.
Patterson Companies, Inc.
-6.46%
-16.47%
0.6%
-11.47%
28.8%
Cardinal Health, Inc.
Cardinal Health, Inc.
0.03%
21.2%
34.8%
102.13%
92.46%
Cencora Inc
Cencora Inc
6.51%
29.88%
29.88%
94.01%
122.67%
Mckesson Corporation
Mckesson Corporation
3.99%
18.99%
40.17%
184.7%
284.04%
Henry Schein, Inc.
Henry Schein, Inc.
1.07%
-1.05%
-7.76%
14.66%
26.11%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Patterson Companies, Inc.
Patterson Companies, Inc.
13.83
13.83
2.1
2.36
0.19
0.06
0.04
11.21
Cardinal Health, Inc.
Cardinal Health, Inc.
41.45
41.45
0.33
7.3
0.0
0.03
0.02
-14.13
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
23.09
23.09
4.8
27.61
0.0
0.04
0.0
-15.62
Henry Schein, Inc.
Henry Schein, Inc.
22.34
22.34
1.73
4.54
0.09
0.06
NA
28.1
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Patterson Companies, Inc.
Patterson Companies, Inc.
Hold
$2.6B
28.8%
13.83
3.05%
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$25.4B
92.46%
41.45
0.3%
Cencora Inc
Cencora Inc
Buy
$38.5B
122.67%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$67.2B
284.04%
23.09
0.99%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.8B
26.11%
22.34
3.51%

Institutional Holdings

  • BlackRock Inc

    11.39%
  • Vanguard Group Inc

    9.99%
  • Dimensional Fund Advisors, Inc.

    4.23%
  • State Street Corporation

    3.28%
  • Nordea Investment Mgmt Bank Demark A/s

    2.80%
  • River Road Asset Management, LLC

    2.73%

Corporate Announcements

  • Patterson Companies, Inc. Dividends March,2024

    In the quarter ending March,2024. Patterson Companies, Inc. has declared dividend of $0.26

    Read More

Company Information

patterson companies is an industry-leading specialty distributor serving the dental and veterinary supply markets. driven to meet the needs of healthcare professionals in these growing markets, patterson provides a total-package approach to doing business. dental market patterson dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout north america. veterinary market patterson veterinary supply and animal health international are leading distributors of consumable supplies, equipment and software, diagnostic products, vaccines and other pharmaceuticals to the companion pet, production animal, and farm/fleet store markets in the united states, canada and the united kingdom. visit our company website at www.pattersoncompanies.com/

Organization
Patterson Companies, Inc.
Employees
7600
CEO
Mr. Donald J. Zurbay
Industry
Wholesale Trade

FAQs